Your browser doesn't support javascript.
Mesenchymal stem cells: ideal seeds for treating diseases.
Gao, Guanwen; Fan, Chenyang; Li, Weiquan; Liang, Runzhang; Wei, Chuzhong; Chen, Xiaojie; Yang, Yue; Zhong, Yueyuan; Shao, Yingqi; Kong, Yi; Li, Zesong; Zhu, Xiao.
  • Gao G; School of Laboratory Medicine, The First Affiliated Hospital, Bengbu Medical College, Bengbu, China.
  • Fan C; Clinical Research Center, The First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan, China.
  • Li W; Department of Clinical Medicine, Medicine and Technology School of Zunyi Medical University, Zunyi, China.
  • Liang R; Clinical Research Center, The First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan, China.
  • Wei C; Clinical Research Center, The First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan, China.
  • Chen X; Clinical Research Center, The First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan, China.
  • Yang Y; Clinical Research Center, The First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan, China.
  • Zhong Y; Clinical Research Center, The First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan, China.
  • Shao Y; Clinical Research Center, The First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan, China.
  • Kong Y; Clinical Research Center, The First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan, China.
  • Li Z; Clinical Research Center, The First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan, China.
  • Zhu X; Guangdong Provincial Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Department of Urology, Shenzhen Second People's Hospital (Shenzhen Institute of Translational Medicine), The First Affiliated Hospital of Shenzhen University, Shenzhen, China. lzssc@email.szu.edu.cn.
Hum Cell ; 34(6): 1585-1600, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1316345
ABSTRACT
Mesenchymal stem cells (MSCs), a kind of multipotent stem cells with self-renewal ability and multi-differentiation ability, have become the "practical stem cells" for the treatment of diseases. MSCs have immunomodulatory properties and can be used to treat autoimmune diseases, such as systemic lupus erythematosus (SLE) and Crohn's disease. MSCs also can be used in cancer and aging. At present, many clinical experiments are using MSCs. MSCs can reduce the occurrence of inflammation and apoptosis of tissue cells, and promote the proliferation of endogenous tissue and organ cells, so as to achieve the effect of repairing tissue and organs. MSCs presumably also play an important role in Corona Virus Disease 2019 (COVID-19) infection.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mesenchymal Stem Cells / Cell- and Tissue-Based Therapy / COVID-19 Type of study: Prognostic study Limits: Animals / Humans Language: English Journal: Hum Cell Year: 2021 Document Type: Article Affiliation country: S13577-021-00578-0

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mesenchymal Stem Cells / Cell- and Tissue-Based Therapy / COVID-19 Type of study: Prognostic study Limits: Animals / Humans Language: English Journal: Hum Cell Year: 2021 Document Type: Article Affiliation country: S13577-021-00578-0